Tradewinds LLC. Has $691,000 Stake in Alpha Teknova, Inc. (NASDAQ:TKNO)

Tradewinds LLC. lifted its holdings in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) by 205.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 133,088 shares of the company's stock after buying an additional 89,538 shares during the quarter. Tradewinds LLC. owned about 0.25% of Alpha Teknova worth $691,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Squarepoint Ops LLC lifted its holdings in Alpha Teknova by 8.4% during the 4th quarter. Squarepoint Ops LLC now owns 30,985 shares of the company's stock worth $259,000 after buying an additional 2,388 shares in the last quarter. Two Sigma Investments LP lifted its stake in shares of Alpha Teknova by 46.2% during the fourth quarter. Two Sigma Investments LP now owns 15,148 shares of the company's stock valued at $126,000 after acquiring an additional 4,789 shares during the period. OMERS ADMINISTRATION Corp acquired a new position in shares of Alpha Teknova during the fourth quarter valued at $335,000. Bank of America Corp DE lifted its stake in shares of Alpha Teknova by 1.8% during the fourth quarter. Bank of America Corp DE now owns 221,285 shares of the company's stock valued at $1,848,000 after acquiring an additional 3,904 shares during the period. Finally, 683 Capital Management LLC acquired a new position in Alpha Teknova during the 4th quarter valued at about $744,000. 13.81% of the stock is owned by institutional investors.

Alpha Teknova Trading Up 1.2%

Alpha Teknova stock traded up $0.06 during trading hours on Tuesday, reaching $5.05. 196,303 shares of the company's stock traded hands, compared to its average volume of 422,591. The company has a debt-to-equity ratio of 0.17, a quick ratio of 4.71 and a current ratio of 5.64. Alpha Teknova, Inc. has a fifty-two week low of $1.16 and a fifty-two week high of $10.37. The firm has a market capitalization of $269.87 million, a price-to-earnings ratio of -10.52 and a beta of 0.33. The firm's 50 day moving average is $5.86 and its 200-day moving average is $6.66.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.02. The business had revenue of $9.60 million for the quarter, compared to analyst estimates of $9.41 million. Alpha Teknova had a negative net margin of 60.90% and a negative return on equity of 28.48%. On average, analysts predict that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Insiders Place Their Bets

In other Alpha Teknova news, Director Martha J. Demski sold 8,000 shares of the stock in a transaction dated Friday, June 27th. The stock was sold at an average price of $5.06, for a total value of $40,480.00. Following the transaction, the director owned 12,000 shares of the company's stock, valued at approximately $60,720. This represents a 40.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 12.50% of the company's stock.

Alpha Teknova Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.